Highlights Bioasis Technologies Inc.

Equities

BTI

CA09064N1033

Delayed Toronto S.E. Other stock markets 09:30:00 21/03/2024 pm IST			5-day change	1st Jan Change
0.005 ^CAD	-.--%		-.--%	-.--%

2023	Bioasis Technologies Inc. Announces Terminating the Non-Exclusive Research Collaboration and Licensing Agreement with Chiesi Farmaceutici S.P.A	CI
2023	Bioasis Technologies Slumps 25% As Provides Update on Financial Position	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bioasis Technologies Inc. Announces Terminating the Non-Exclusive Research Collaboration and Licensing Agreement with Chiesi Farmaceutici S.P.A	21/23/21	CI
Midatech Pharma plc cancelled the acquisition of Bioasis Technologies Inc..	23/23/23	CI
Bioasis Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2022	20/23/20	CI
BiOasis Technologies, Inc. and Midatech Pharma plc Merger Call	20/22/20	FA
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc	13/22/13	GL
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc	13/22/13	GL
Midatech Pharma plc entered into a definitive agreement to acquire Bioasis Technologies Inc. from The Lind Partners, LLC and others for $5.5 million.	13/22/13	CI
Bioasis Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2022	29/22/29	CI
Bioasis Technologies Inc. Reports Earnings Results for the First Quarter Ended May 31, 2022	30/22/30	CI
Bioasis Technologies Buys Phase 2 Ready Rare Orphan EGF Assets From Norwegian Company	16/22/16	MT
Bioasis Technologies Inc. Reports Earnings Results for the Full Year Ended February 28, 2022	15/22/15	CI
Bioasis Technologies and Neuramedy of South Korea Enter into Research Collaboration and License Agreement	11/22/11	MT
Bioasis Technologies Inc. and Neuramedy Co Ltd Enter into Research Collaboration and License Agreement	11/22/11	CI
Bioasis Technologies Inc. Enters Research Collaboration with Janssen Biotech, Inc	12/22/12	CI
Bioasis Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2021	21/22/21	CI
Bioasis Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2021	29/21/29	CI
Bioasis Technologies Brief: nnounces Allowance of Japanese Patent Application in Japan Relating to Fusion Protein Comprising Iduronate-2-sulfatase	10/21/10	MT
Bioasis Technologies Inc. Reports Earnings Results for the First Quarter Ended May 31, 2021	30/21/30	CI
Bioasis Technologies Inc. Announces Positive Results from Efficacy Study of xB3™-IL-1RA in Model of Multiple Sclerosis	08/21/08	CI
Bioasis Technologies : Names New CFO	02/21/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bioasis Technologies Inc.

Equities

BTI

CA09064N1033

Highlights

Filters